The International Stroke Conference 2024 will be held Feb. 7-9 in Phoenix, Arizona. According to program planners with the American Stroke Association, a division of the American Heart Association, findings from late-breaking science will include multiple high profile randomized clinical trials like RESILIENT-Extend, EMBOLISE, STEM, ZODIAC, among many others.
Groundbreaking data published in the NEJM questioned the commonly accepted 24-hour time window for administering dual antiplatelet therapy following a mild ischemic stroke.
Utilizing user-friendly, swiftly applicable electrodes, subhairline EEG may improve stroke detection and reduce time to treatment for anterior circulation large vessel occlusion stroke.